Small Cancer Therapy Player Celularity To Provide Research Support For Regeneron's Therapy - Celularity (NASDAQ:CELU), Regeneron Pharmaceuticals (NASDAQ:REGN)

Celularity Inc (NASDAQ: CELU) shares are trading higher after the company announced a multi-year Research Collaboration Services Agreement with Regeneron Pharmaceuticals Inc (NASDAQ: REGN).

Related Keywords

Celularity Inc , ,Regeneron Pharmaceuticals Inc ,Research Collaboration Services Agreement ,Regeneron Pharmaceuticals ,Florham Park ,